The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

Diabetes Care

Volumn 22, Issue 2, 1999, Pages 233-240

  Coutinho, Mario ^a,b,c   Gerstein, Hertzel C ^a,b,d   Wang, Yong ^a   Yusuf, Salim ^a,b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d Department of Medicine ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DATA ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS;

ADULT; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 0032902850     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.2.233     Document Type: Article

References (65)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
3. Goldbourt U, Yaari S, Medalie JH: Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees: a 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology 82:100-121, 1993
4. Moss SE, Klein R, Klein BEK, Meuer SM: The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 154:2473-2479, 1994
5. Andersson DKG, Svardsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18:1534-1543, 1995
6. Kuusisto J, Mykkanen L, Pyorala K, Laakso M: NIDDM and its metabolic control predict coronary heart disease in elderly subjects Diabetes 43:960-967, 1994
7. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, Wedel H, Welin L: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study Group): effects on mortality at 1 year. J Am Coll Cardiol 26:57-65, 1995
8. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
9. Leahy JL, Bonner-Weir S, Weir GC: β-cell dysfunction induced by chronic hyperglycemia: current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care 15:442-454, 1992
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197, 1997
11. Whitehead A, Whitehead J: A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10:1665-1677, 1991
12. McCullagh P, Nelder JA: Generalized Linear Models. 2nd ed. London, Chapman and Hall, 1989
13. Cochran WG: The combination of estimates from different experiments. Biometrics 10:101-129, 1954
14. Stamler R, Stamler J, Lindberg HA, Marquardt J, Berkson DM, Paul O, Lepper M, Dyer A, Stevens E: Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chronic Dis 32:805-815, 1979
15. Stenhouse NS, Murphy BP, Welborn TA: Busselton Population Study: risk associated with asymptomatic hyperglycemia. J Chron Dis 32:693-698, 1979
16. Pyorala K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P: Glucose tolerance and coronary heart disease: Helsinki Policemen Study. J Chron Dis 32:729-745, 1979
17. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Mortality from coronary heart disease and stroke in relation to degree of glycemia: the Whitehall Study. Br Med J 287:867-870, 1983
18. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 36:689-692, 1987
19. Scheidt-Nave C, Barrett-Connor E, Wingard DL, Cohn BA, Edelstein SL: Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol 133:565-576, 1991
20. Vaccaro O, Ruth KJ, Stamler J: Relationship of postload plasma glucose to mortality with 19-year follow-up. Diabetes Care 15:1328-1334, 1992
21. Balkau B, Eschwege E, Papoz L, Richard JL, Claude JR, Warnet JM, Ducimetiere P: Risk factors for early death in non-insulin dependent diabetes and men with known glucose tolerance status. BMJ 307:295-299, 1993
22. Tuomilehto J, Schranz A, Aldana D, Pitkaniemi J: The effect of diabetes and impaired glucose tolerance on mortality in Malta. Diabet Med 11:170-176, 1994
23. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG: Asymptomatic hyperglycaemia and major ischemic heart disease events in Britain. J Epidemiol Comm Health 48:538-542, 1994
24. Shaten BJ, Kuller LH, Neaton JD, MRFIT Research Group: Association between baseline risk factors, cigarette smoking, and CHD mortality after 10.5 years. Prev Med 20:655-669, 1991
25. Da Silva A, Widmer LK, Ziegler HW, Nissen C, Schweizer W: The Basle Longitudinal Study: report on the relation of initial glucose level to baseline ECG abnormalities, peripheral artery disease, and subsequent mortality. J Chronic Dis 32:797-803, 1979
26. Hawthorne VM, Gilmour WH: Relationship of glucose to prevalence of ECG abnormalities at baseline and to 6-year mortality in Scottish males aged 45-64 yr. J Chron Dis 32:787-796, 1979
27. Reunanen A, Pyorala K, Aromaa A, Maatela J, Knekt P: Glucose tolerance and coronary heart disease in middle aged Finnish men: Social Insurance Institution's Coronary Heart Disease Study. J Chron Dis 32:747-758, 1979
28. Cruz-Vidal M, Garcia-Palmieri MR, Costas R. Sorlie PD, Havlik RJ: Abnormal blood glucose and coronary heart disease: the Puerto Rico Heart Health Program. Diabetes Care 6:556-561, 1983
29. Yarnell JWG, Pickering JE, Elwood PC, Baker IA, Bainton D, Dawkins C, Phillips DIW: Does nondiabetic hyperglycemia predict future IHD? evidence from the Caerphilly and Speedwell studies. J Clin Epidemiol 47:383-388, 1994
30. Schroll M, Hagerup L: Relationship of fasting blood glucose to prevalence of ECG abnormalities and 10 year risk of mortality from cardiovascular diseases in men born in 1914: from the Glostrup Population Studies. J Chron Dis 32:699-707, 1979
31. Ohlson LO, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, Tibblin G, Larsson B: Fasting blood glucose and risk of coronary heart disease, stroke, and all-cause mortality: a 17-year follow-up study of men born in 1913. Diabetic Med 3:33-37, 1986
32. Lund Haheim L, Holme I, Hjermann I, Leren P: Nonfasting serum glucose and the risk of fatal stroke in diabetic and nondiabetic subjects: 18 year follow-up of the Oslo study Stroke 26:774-777, 1995
33. Grabauskas VJ: Glucose intolerance as contributor to noncommunicable disease morbidity and mortality. Diabetes Care 11:253-257, 1988
34. Kohl HW, Gordon NF, Villegas JA, Blair SN: Cardiorespiratory fitness, glycemic status, and mortality risk in men. Diabetes Care 15:184-192, 1992
35. Wilson PWF, Cupples A, Kannel WB: Is hyperglycemia associated with cardiovascular disease? the Framingham study. Am Heart J 121:586-590, 1991
36. Barrett-Connor E, Wingard DL, Criqui MH, Suarez L: Is borderline fasting hyperglycemia a nsk factor for cardiovascular death? J Chron Dis 37:773-779, 1984
37. Butler WJ, Ostrander LDJ, Carman WJ, Lamphiear DE: Mortality from coronary heart disease in the Tecumseh study: long-term effect of diabetes mellitus, glucose tolerance and other risk factors. Am J Epidemiol 121:541-547, 1985
38. Pan W, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J: Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 123:504-516, 1986
39. Janghorbani M, Jones RB, Harper Gilmour W, Hedley AJ, Zhianpour M: A prospective population based study of gender differential in mortality from cardiovascular disease and "all causes" in asymptomatic hyperglycemics. J Clin Epidemiol 47:397-405, 1994
40. Miller GJ, Kirkwood BR, Beckles GLA, Alexis SD, Carson DC, Byam NTA: Adult male all-cause, cardiovascular and cerebrovascular mortality in relation to ethnic group, systolic blood pressure, and blood glucose concentration in Trinidad, West Indies. Int J Epidemiol 17:62-69, 1988
41. Tomas-Abadal L, Varas-Lorenzo C, Bernades-Bernat E, Balaguer-Vintro I: Coronary risk factors and 20-year incidence of coronary heart disease and mortality in a 20-year Mediterranean industrial population: the Manresa study, Spain. Euro Heart J 15:1028-1036, 1994
42. Jarrett RJ, McCartney P, Keen H: The Bedford survey: ten-year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia 22:79-84, 1982
43. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
44. Viberti G: A glycemic threshold for diabetic complications? N Engl J Med 332:1293-1294, 1995
45. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
46. Casiglia E, Pauletto P, Mazza A, Ginocchio G, di Menza G, Pavan L, Tramontin P, Capuani M, Pessina AC: Impaired glucose tolerance and its covariates among 2079 non-diabetic elderly subjects. Acta Diabetol 33:284-290, 1996
47. Feskens EJM, Kromhout D: Glucose tolerance and the nsk of cardiovascular diseases: the Zutphen study. J Clin Epidemiol 45:1327-1334, 1992
48. Balkau B, Shipley M, Jarrett RJ, Pyorala K, Pyorala M, Forhan A, Eschwege E: High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. Diabetes Care 360:360-367, 1998
49. Orencia AJ, Daviglus ML, Dyer AR, Walsh M, Greenland P, Stamler J: One-hour postload glucose and risks of fatal coronary heart disease and stroke among nondiabetic men and women: the Chicago Heart Association Detection Project in Industry (CHA) Study. J Clin Epidemiol 50:1369-1376, 1997
50. Lowe LP, Liu K, Greenland P, Metzger BE, Dyer AR, Stamler J: Diabetes, asymptomatic hyperglycemia and 22-year mortality in black and white men: the Chicago Heart Association Detection Project in Industry Study. Diabetes Care 20:163-169, 1997
51. Singer DE, Nathan DM, Anderson KM, Wilson PWF, Evans JC: Association of HbAlc with prevalent cardiovascular disease in the original cohort of the Framingham heart study. Diabetes 41:202-208, 1992
52. Pais P, Pogue J, Gerstein H, Zachanah E, Savitha D, Jayprakash S, Nayak PR, Yusuf S: Risk factors for acute myocardial infarction in Indians: a case-control study. Lancet 348:358-363, 1996
53. Baynes JW: Role of oxidative stress in development of complications of diabetes. Diabetes 40:405-412, 1991
54. Lyons TJ: Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 71:26B-31B, 1993
55. Giugliano D, Cenello A, Paolisso G: Oxidative stress and diabetic complications. Diabetes Care 19:257-267, 1996
56. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41:67-73, 1992
57. Vlassara H, Bucala R, Striker L: Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138-151, 1994
58. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-841, 1994
59. Laws A, Reaven GM: Insulin resistance and risk factors for coronary heart disease. Bailliere's Clin Endocrinol Metab 7:1063-1078, 1993
60. Stern MP: Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes 44:369-374, 1995
61. Jarrett RJ: The cardiovascular risk associated with impaired glucose tolerance. Diabetic Med 13 (Suppl. 2):S15-S19, 1996
62. Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein SL: GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: the Rancho Bernardo Study. Diabetes Care 19:450-456, 1996
63. Wingard DL, Barrett-Connor E, Ferrara A: Is insulin really a heart disease risk factor? Diabetes Care 18:1299-1304, 1995
64. Gerstein HC, Yusuf S: Dysglycaemia and risk of cardiovascular disease. Lancet 347:949-950, 1996
65. Pyorala K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 701:38-52, 1985